Showing results (211-220 of 222) with videos related to
Sort By:
Pageof 23
Circulation. Cardiovascular Interventions|February 19, 2020
Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting StentKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.Frontiers in Cardiovascular Medicine|January 9, 2023
Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patientsJung-Joon Cha, Soon Jun Hong, Ju Hyeon Kim, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 17, 2025
Final kissing balloon dilatation in patients with coronary bifurcation lesions treated with an upfront provisional stenting strategyOvidio De Filippo, Jeehoon Kang, Francesco Bruno, et al.Journal of Clinical Medicine|July 24, 2021
Differential Factors for Predicting Outcomes in Left Main versus Non-Left Main Coronary Bifurcation StentingJung-Joon Cha, Soon Jun Hong, Hyung Joon Joo, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|July 27, 2022
Long-Term Clinical Outcomes and Its Predictors Between the 1- and 2-Stent Strategy in Coronary Bifurcation Lesions - A Baseline Clinical and Lesion Characteristic-Matched AnalysisAlbert Youngwoo Jang, Minsu Kim, Pyung Chun Oh, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|June 3, 2021
Comparison of 2-Stenting Strategies Depending on Sequence or Technique for Bifurcation Lesions in the Second-Generation Drug-Eluting Stent Era - Analysis From the COBIS (Coronary Bifurcation Stenting) III RegistryJeehoon Kang, Jung-Kyu Han, Han-Mo Yang, et al.The American Journal of Cardiology|August 6, 2021
Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)Ovidio De Filippo, Jeehoon Kang, Francesco Bruno, et al.Journal of the American Heart Association|September 13, 2021
Ten-Year Trends in Coronary Bifurcation Percutaneous Coronary Intervention: Prognostic Effects of Patient and Lesion Characteristics, Devices, and TechniquesJoo Myung Lee, Seung Hun Lee, Juwon Kim, et al.Lancet (London, England)|April 2, 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Yong Hwan Park, Jong-Young Lee, et al.Clinical Therapeutics|September 24, 2017
Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III StudySoon Jun Hong, Han Saem Jeong, Seung Hwan Han, et al.Pageof 23